oral glp 1 agonist for type 2 diabetes Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Choosing injectable drugs for patients
Description
as the diagnosis of clinical obesity will be redefined, while evidence substantiating the value of AOMs begins to accumulate in the real world
Retatrutide activates GIPR and GCGR , achieving over 20% weight loss in phase 2 trials
Sci Transl Med 9(404):eaan0972 Mitchell JL et al (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
As our understanding deepens, we can expect even more powerful, targeted, and safer medications that harness the full potential of GLP-1 biology
GLP-1 drug liraglutide may protect against dementia
